banner add

Executives Depart Cassava, Maker of Disputed Alzheimer’s Drug

The chief executive and a lead scientist stepped down weeks after a federal grand jury filed fraud charges against a research collaborator.

from NYT > Health https://ift.tt/pTq5nkA
via IFTTT

No comments

U.S.A.I.D. Memos Detail Human Costs of Cuts to Foreign Aid

The world is likely to see millions more malaria infections and 200,000 cases of paralytic polio each year, according to an agency whistle-b...

Theme images by PLAINVIEW. Powered by Blogger.